摘要
目的 观察诺为片 (马来酸曲美布汀 )加舒必利片对功能性消化不良的治疗效果。 方法 将 2 0 0 2年～ 2 0 0 3年我院住院及门诊 FD患者随机分为两组 ,治疗组 42例 ,给予诺为片每日 3次 ,每次 2 0 0 mg,餐前 15 min服用。舒必利片每日 2次 ,每次 1片 ,餐前 15 min服用。对照组 41例 ,单独使用诺为片 ,每日 3次 ,每次 2 0 0 mg,餐前 15 min服用。 2周后观察疗效。 结果 对各种消化道症状进行比较 ,治疗组高于对照组 (P<0 .0 5 )。 结论 舒必利可提高马来酸曲美布汀的疗效 ,且不良反应较轻。
OBJECTIVE Observe the therapeutical effect of the diway and sulpipide tablets to functional dyspepsia.METHODS Divide the in-patient and outpatient of FD during 2002～2003 in our hospital into two groups named therapeutic and contrastive group.The former 42 samples are given diway tablets 200mg three times a day, 15 minutes before food;Sulpiride tablets one tablet twice a day, 15 minutes before food.The contrastive group 41 sample, are given diway tablets only,200mg three times a day, 15 minutes before food.Observe the therapeutical effect 2 weeks later. RESULTS Compare the every symptoms of digestive tract,former group is higher than the latter(P<0.05).CONCLUSION Sulpiride can improve the therapeutical effect of trimebutine-maleate and with a little untoward effect.
出处
《海峡药学》
2004年第3期93-94,共2页
Strait Pharmaceutical Journal
